908 Devices Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from 908 Devices Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 20% in 3 years; of every extra $100 of sales, $568 became extra profit. Higher than 94% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-21.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 58% of Healthcare companies in United States.
Cash Locked Ratio
$40For every $100 of sales, $40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $45 tied up three years earlier.
More money tied up than 82% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
$568Sales grew 20% in 3 years; of every extra $100 of sales, $568 became extra profit.
Higher than 94% of Healthcare companies in United States.
Asset Productivity Ratio
+20% / -22%In 3 years sales changed by +20% while total assets changed by -22%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-34.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 66% of Healthcare companies in United States.
Cash Cushion Ratio
+23%Cash, after subtracting all debt, equals 23% of its market value (net cash).
Higher than 65% of Healthcare companies in United States.
Tangible Assets Ratio
81%Of every $100 the company owns, $81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 51% of Healthcare companies in United States.
Tangible Net Worth Ratio
75%Of every $100 of net worth, $75 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 58% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
908 Devices Inc. made a loss over the last year. 908 Devices Inc. owes $0.36 for every $1 it owns. 908 Devices Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
Loss908 Devices Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.70The share price is 3.70 times 908 Devices Inc.'s book value per share, higher than 62% of Healthcare companies in United States.
Market cap
$469 MThe total market value of all of 908 Devices Inc.'s shares at today's price (share price × number of shares), larger than 54% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$127 MWhat 908 Devices Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.07Net worth divided by the number of shares. The share price of $11.35 is 3.7 times this, which is the P/B above.
Return on equity (ROE)
-24.9%908 Devices Inc. lost 24.9% of its shareholders' money over the last year, higher than 64% of Healthcare companies in United States.
Owes vs Owns
0.36×908 Devices Inc. owes $0.36 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Dividend yield
None908 Devices Inc. does not currently pay a dividend.
Revenue growth
+18%Revenue rose 18% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
Back to profit908 Devices Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
34.7%908 Devices Inc. keeps $35 of every $100 of revenue as net profit.
Cash quality
-1.2×Cash from 908 Devices Inc.'s business was -1.2× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Cash vs debt
Net cash908 Devices Inc. held $108 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For 908 Devices Inc.: $469 M ÷ $127 M (30 Jun 2026) = 3.7.
What is 908 Devices Inc.'s return on equity?
908 Devices Inc. lost 24.9% of its shareholders' money over the last year, higher than 64% of Healthcare companies in United States.
How much does 908 Devices Inc. owe compared with what it owns?
908 Devices Inc. owes $0.36 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Does 908 Devices Inc. pay a dividend?
No. 908 Devices Inc. does not currently pay a dividend.
Is 908 Devices Inc.'s revenue growing?
Revenue rose 18% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.